Drawing for JUNCTION

USPTO serial 99123414

JUNCTION

Reviewed by CopyMark Law Group

Status 760
Filing date
Status date
Registration date
—
Examiner
FOUTS, KAREN JEANNE SEPUR
Law office
TMEG LAW OFFICE 101

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JUNCTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RYAN S. HILBERT

RYAN S. HILBERT HOLLEY & MENKER PAPO Box 331937Atlantic Beach, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
042Platform as a Service (PAAS) featuring computer software platforms for use in facilitating access to and the exchange of medical information and medical diagnostics data between physicians, patients, laboratories, healthcare providers and healthcare vendors; Platform as a Service (PAAS) featuring computer software platforms for use in medical treatment planning and diagnoses and facilitating diagnostic workflows; Platform as a Service PAAS featuring computer software platforms for facilitating access to medical diagnostic testing, monitoring, and reporting services through integration with third-party laboratories, healthcare providers, and diagnostic platforms; Platform as a Service (PAAS) featuring computer software platforms for use in collecting, storing, compiling, analyzing, sharing, exporting and transmitting data and information from wireless monitoring devices, medical devices and medical wearables to physicians, patients, laboratories, clinics and healthcare vendors; Platform as a Service (PAAS) featuring computer software platforms for the collection, aggregation, interpretation, analysis, integration, visualization, notification and distribution of personal health information for use in remote monitoring and data analysis; Platform as a Service (PAAS) featuring computer software platforms for use in locating laboratories, clinics and healthcare vendors and for use in ordering and reviewing medical testing, diagnostics and results; Providing temporary use of online non-downloadable software development kits (SDKs); Computer consulting services for the creation of healthcare information technology; Development, updating, and maintenance of software and database systems in the field of health and medicine; Technical support services, namely, providing implementation support and configuration guidance for customers using proprietary healthcare software platforms; Platform as a Service (PAAS) featuring computer software platforms for coordinating self-administered specimen collection, including managing the ordering, packaging, labeling, and shipping of test kits for laboratory analysis, and for tracking logistics and status of specimen transit and results deliveryACTIVEMar 11, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2026ALIEASSIGNED TO LIE—
Oct 5, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 5, 2026EXPIEX PARTE APPEAL-INSTITUTED—
Oct 5, 2026JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Oct 5, 2026EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 1, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 1, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 3, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 3, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 3, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 5, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 4, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 6, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2025DOCKASSIGNED TO EXAMINER—
Aug 18, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 7, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance